|
![]() |
|
|
Cefixime: profile and news
Steep fall in prices of medicines Feb 19, 2006 An open letter to the pharmaceutical industry Jan 29, 2006 Prescribing medicine in Ramzan Oct 20, 2005 Lupin gets USFDA nod Aug 18, 2005 Treating Partners Immediately Reduces Recurrence of STDs Jul 31, 2005 US tonic helps Lupin dream big Jul 8, 2005 US tonic helps Lupin dream big Jul 8, 2005 Lupin in marketing pact with US firms May 29, 2005 Lupin strikes outlicencing deal with Cornerstone May 13, 2005 Gay men continue to see gonorrhoea rises May 5, 2005 Lupin looks to beef up US presence, eyes $100m buy Mar 3, 2005 Lupin's unsexy, but great, success story! Mar 3, 2005 Immediate Access To Antibiotics Stems Spread Of Sexually ... Mar 4, 2005 Other information Indication For the treatment of the following infections (UTI, respiratory, ENT) caused by; E.coli, P.mirabilis, H.influenzae (beta-lactamase positive and negative strains), M.catarrhalis, (most of which are beta-lactamase positive), S. pyogenes, S.pneumoniae, N.gon Pharmacology Cefixime, an antibiotic, a third-generation cephalosporin like ceftriaxone and cefotaxime, is used in the treatment of otitis media, and respiratory tract and urinary tract infections. The antibacterial effect results from inhibition of mucopeptide synthesis in the bacterial cell wall Mechanism Of Action Like all beta-lactam antibiotics, cefixime binds to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, causing the inhibition of the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that cefixime interferes with an autolysin inhibitor. Drug Category Anti-bacterial Agents; Cephalosporins; ATC:J01DD08 Brand Names/Synonyms CFIX; Cefixim; Cefixima [Spanish]; Cefixime; Cefixime Anhydrous; Cefixime [Usan:Ban:Inn:Jan]; Cefiximum [Latin]; Cefixoral; Cefspan; Cephoral; FK 027; Oroken; Suprax; Unixime Dosage Forms Oral Suspension; Tablet; POWDER FOR SOLUTION; POWDER FOR SUSPENSION Absorption Orally 40-50% Interactions -->Interactions for Cefixime: Carbamazepine: Elevated carbamazepine levels have been reported in postmarketing experience when SUPRAX is administered concomitantly. Drug monitoring may be of assistance in detecting alterations in carbamazepine plasma concentrations. Warfarin and Anticoagulants: Increased prothrombin time, with or without clinical bleeding, has been reported when cefixime is administered concomitantly. Drug/Laboratory Test Interactions A false-positive reaction for ketones in the urine may occur with tests using nitroprusside but not with those using nitroferricyanide. The administration of SUPRAX may result in a false-positive reaction for glucose in the urine using ClinitestÒ**, Benedictís solution, or Fehlingís solution. It is recommended that glucose tests based on enzymatic glucose oxidase reactions (such as Clinistix®** or Tes-TapeÒ**) be used. A false-positive direct Coombs test has been reported during treatment with other cephalosporin antibiotics; therefore, it should be recognized that a positive Coombs test may be due to the drug. Chemical IUPAC Name 8-[2-(2-amino-1,3-thiazol-4-yl)-2-(carboxymethoxyimino)acetyl]amino-4-ethenyl-7-oxo-2-thia-6-azabicyclo[4.2.0]oct-4-ene-5-carboxylic acid Chemical Formula C16H15N5O7S2 Half Life 3-4 hours Drug Type Approved Drug # Accession No APRD00583 CAS Registry Number 79350-37-1 |
|
Home | About | Cancers | Treatment | Medications Copyright onconews.org 2005. All Rights Reserved. |